Inside every stressed cell, a quiet emergency response unfolds. When oxygen runs low, toxins accumulate, or nutrients grow scarce, mammalian cells assemble temporary structures known as stress granules, non-membranous aggregates of proteins and RNA that condense in the cytoplasm. In healthy tissue, these assemblies act as a protective pause button, halting protein production so the cell can weather the storm and resume normal function once conditions improve. But a new study suggests that in oral squamous cell carcinoma, one of the most common and disfiguring malignancies of the head and neck, this ancient survival machinery may be hijacked to serve a darker purpose: helping tumors grow and spread.

The research, conducted by a team at Kangwon National University in South Korea and published in Cell Death Discovery, examined how stress granule formation influences tumor progression and metastasis in oral squamous cell carcinoma, or OSCC. The findings point to a specific molecular switch, the phosphorylation of a protein called eIF2α, as a central driver of the process. When that switch is suppressed, the study reports, stress granule formation drops, and with it the growth and metastatic burden of tumors in mouse models. The work adds oral cancer to a growing list of malignancies in which the integrated stress response appears to fuel, rather than restrain, disease.

To understand why this matters, it helps to consider what stress granules actually do. Under stress, cells activate kinases that phosphorylate eIF2α, the alpha subunit of a translation initiation factor. Phosphorylated eIF2α dampens global protein synthesis, and the messenger RNAs that would otherwise be translated are instead sequestered, along with RNA-binding proteins, into dense cytoplasmic droplets. Key markers of these structures include G3BP1, TIAR, and PABP, proteins that researchers use to identify stress granules under the microscope. In normal cells, this translational arrest conserves energy and prevents the accumulation of damaged or misfolded proteins. The system is meant to be reversible: when the stress passes, the granules dissolve and translation restarts.

Cancer cells, however, live in a state of chronic stress. Tumors outgrow their blood supply, creating regions of hypoxia, low oxygen tension that would kill most normal cells. They also face nutrient deprivation, acidic microenvironments, and assault from chemotherapy and radiation. In this context, the stress response can become a liability for the patient rather than a safeguard for the cell. Previous work in other cancers has implicated stress granules in tumor progression and metastasis, partly through their interactions with key signaling pathways, but their role in oral squamous cell carcinoma had remained poorly understood, despite growing scientific interest in the topic.

The Korean team began by comparing human tumor tissue with adjacent normal tissue. They found that markers of stress granules, including G3BP1, eIF2α, TIAR, and PABP, were significantly overexpressed in OSCC tissues compared with their normal counterparts. This observation established that the stress granule machinery is not merely present in oral cancer but is amplified, suggesting that tumor cells may rely on it more heavily than the healthy cells around them. Overexpression of these markers alone does not prove causation, but it set the stage for the functional experiments that followed.

Those experiments turned to mouse models built from OSCC cells that had been preconditioned with hypoxia, deliberately exposing the cells to low oxygen before implantation. The logic was to mimic the stressful conditions tumor cells encounter in a real growing tumor and to ask whether cells that had already mounted a stress response behaved differently afterward. In parallel, the researchers used a compound called ISRIB, an inhibitor of the integrated stress response that acts downstream of eIF2α phosphorylation, in mice subjected to sodium arsenite-induced stress. Sodium arsenite is a classic laboratory trigger of oxidative stress and a reliable inducer of stress granule formation, making it a useful tool for probing the pathway.

The results were striking. In both experimental settings, suppression of eIF2α phosphorylation was associated with reduced stress granule formation, reduced tumor growth, and a reduced metastatic burden. In other words, when the researchers blocked the molecular event that nucleates stress granules, the tumors not only grew more slowly but also spread less aggressively. Conversely, the study found that stress granule formation was elevated during hypoxia-induced stress, underscoring a stress-responsive regulatory mechanism in which the harsh conditions of the tumor microenvironment actively promote the assembly of these granules. Together, the data sketch a coherent chain of causation: hypoxia and other stresses trigger eIF2α phosphorylation, phosphorylation drives stress granule assembly, and the granules support the cellular programs that allow OSCC cells to proliferate and colonize distant sites.

Why would a structure designed to protect cells become an engine of metastasis? The authors and other researchers in the field point to the selective nature of stress granules. While global translation is arrested, certain messenger RNAs are preferentially stored within the granules and protected from degradation. Among the transcripts sheltered this way are often those encoding proteins that promote survival, invasion, and epithelial-to-mesenchymal transition, the process by which stationary epithelial cancer cells acquire the motility needed to invade surrounding tissue and enter the bloodstream. By acting as temporary warehouses for pro-metastatic messages, stress granules may allow tumor cells to stockpile the tools of aggression, releasing them for translation once the acute stress subsides. In this view, the granule is not merely a damage-control structure but a staging ground for the next phase of tumor progression.

The therapeutic implications are considerable. Oral squamous cell carcinoma is frequently diagnosed at advanced stages, and metastasis to cervical lymph nodes is one of the strongest predictors of poor outcome. Existing treatments, surgery, radiation, and chemotherapy, remain limited in their ability to control disseminated disease. If stress granule formation genuinely drives metastatic behavior, then the pathway offers a new target. ISRIB, the compound used in the mouse experiments, has attracted attention in recent years for its ability to blunt the integrated stress response, and the new findings suggest that agents with a similar mechanism could be explored as anti-metastatic therapies in oral cancer. The authors conclude that stress granules promote OSCC progression via eIF2α phosphorylation and might serve as a novel therapeutic target, a formulation that is deliberately cautious but clinically suggestive.

As with any preclinical study, important caveats apply. The evidence comes from human tissue comparisons and mouse models, and translating these findings into patients will require further work to confirm that the same mechanism operates in human tumors in real time, to identify which patient subsets have the highest stress granule activity, and to develop inhibitors with acceptable safety profiles. Suppressing a fundamental cellular stress pathway carries risks, since normal tissues also rely on the integrated stress response during injury and inflammation. Still, the study fills a genuine gap in the literature by connecting a well-characterized cellular stress mechanism to one of the most clinically feared behaviors of oral cancer. It also adds to a broader shift in cancer biology: the recognition that tumors are not just collections of mutated genes but ecosystems shaped by physical and chemical stress, and that the survival programs cells use to endure hardship can be turned against the organism that hosts them. For patients with oral squamous cell carcinoma, whose disease too often spreads before it can be stopped, the humble stress granule may prove to be an unexpected and consequential adversary.

Subject of Research: The role of stress-induced eIF2α phosphorylation and stress granule formation in promoting metastasis of oral squamous cell carcinoma

Article Title: Stress-induced eIF2α phosphorylation promotes tumor metastasis in oral squamous cell carcinoma

Article References: Kim, S., Park, S., Lee, Y., Park, G., & Choi, J. (2026). Stress-induced eIF2α phosphorylation promotes tumor metastasis in oral squamous cell carcinoma. Cell Death Discovery. https://doi.org/10.1038/s41420-026-03412-4

Image Credits: AI Generated

DOI: 10.1038/s41420-026-03412-4

Keywords: stress granules, eIF2α phosphorylation, oral squamous cell carcinoma, metastasis, integrated stress response, ISRIB, hypoxia, G3BP1, tumor progression, translational arrest, cancer biology, therapeutic target

The viruses that gave rise to SARS-CoV-2 have been circulating in horseshoe bats and related mammals across Asia for millennia, and most of them have never spilled over into people. Yet a small number of these bat sarbecoviruses clearly can infect humans, as the COVID-19 pandemic demonstrated. A central question for pandemic preparedness has therefore been whether scientists can look at the properties of a newly discovered bat coronavirus and make an evidence-based judgement about how dangerous it might be. A new study published in PLOS Biology suggests that one measurable property, the breadth of species whose ACE2 receptor a virus can use, may be a surprisingly informative signal, predicting not only which animals a virus can infect but also how closely related it is to SARS-CoV-2 in the eyes of the human immune system.

Sarbecoviruses, the subgenus of coronaviruses that includes SARS-CoV and SARS-CoV-2, attach to their host cells through the receptor-binding domain, or RBD, of the Spike protein. This domain grips the angiotensin-converting enzyme 2 receptor, ACE2, on the surface of host cells, and it is also the principal target of neutralising antibodies. That dual role creates an intimate link between host range and antigenicity: the same molecular surface that determines which species’ receptors a virus can engage also determines how well antibodies raised against one virus recognise another. The research team, led by scientists at The Pirbright Institute together with collaborators including researchers at King’s College London, set out to map that relationship systematically across a diverse collection of bat sarbecoviruses.

The experimental strategy combined three complementary approaches. First, the researchers used binding assays to test whether the Spike proteins of different sarbecoviruses could attach to ACE2 proteins from a wide panel of mammalian species. Second, they used pseudotype-entry assays, in which harmless lentiviral particles are decorated with each coronavirus Spike protein, to test whether receptor binding actually translates into cell entry. Third, they measured how sera from SARS-CoV-2 convalescent individuals and monoclonal antibodies from vaccinated people who had experienced breakthrough infections neutralised the different viruses. By running the same viruses through all three assays, the team could directly correlate receptor usage with antigenic behaviour.

The results revealed a striking pattern. Sarbecoviruses in clade 1, the group that contains SARS-CoV-2 itself and the BANAL viruses isolated from bats in Laos, tended to be generalists. Their Spike proteins could productively engage ACE2 receptors from many different bat species, indicating that they are not finely tuned to a single host. In contrast, viruses from clade 3, exemplified by RhGB07, and clade 5, exemplified by Rc-o319, behaved as specialists, using a much narrower range of ACE2 receptors. Rc-o319, which was previously known to be unable to use human ACE2 efficiently, fits this specialist profile, whereas the BANAL viruses, which can use human ACE2, sit firmly in the generalist camp alongside SARS-CoV-2.

To understand the structural basis of this specialism, the team solved a novel structure of the RhGB07 Spike protein. The structure allowed them to identify specific residues within the RBD that are associated with the restricted receptor usage of this clade 3 virus. These residues presumably shape the receptor-binding interface in ways that favour particular bat ACE2 variants while excluding others. Such structural insights are valuable because they point to the molecular features that distinguish viruses capable of flexible receptor engagement from those locked into narrow host ranges, and they may help predict the properties of newly discovered sarbecoviruses from sequence data alone.

When the researchers extended their receptor panel beyond bats to include more diverse mammalian ACE2 proteins, the generalist phenotype largely held. Clade 1 viruses could bind and enter cells expressing ACE2 from humans, non-human primates, livestock, and rodents, as well as from species considered potential intermediate reservoir hosts, such as civets, raccoon dogs, and pangolins. This is significant because intermediate hosts are thought to have played a role in previous coronavirus spillovers, including the emergence of SARS-CoV in 2002. A virus that can already use the receptors of many species faces fewer barriers on the path from bat to human. The specialist viruses, by contrast, showed wider phenotypic diversity across this expanded panel, with RhGB07 exhibiting a more idiosyncratic pattern of receptor usage that did not simply mirror its bat-host profile.

The study also examined how SARS-CoV-2’s ongoing evolution in humans has changed its receptor preferences. Comparing variants that have emerged during the pandemic, the researchers found an expanding and, in some cases, shifting pattern of generalism, particularly for Omicron and its many sub-lineages. Omicron’s Spike has accumulated numerous mutations in the RBD, and these changes appear to have broadened or reconfigured the range of ACE2 molecules the virus can engage. This observation underscores that receptor usage is not a fixed property of a virus but a dynamic trait that can evolve under immune pressure and changing transmission landscapes, with potential consequences for which animal species might serve as new reservoirs for human-derived variants.

The antigenic side of the analysis produced equally important findings. When convalescent sera from people who had recovered from COVID-19 were tested against the panel of bat sarbecoviruses, clade 1 viruses, being phylogenetically closest to SARS-CoV-2, were antigenically the most similar. There was robust evidence for cross-neutralisation of these viruses, meaning that immunity generated against SARS-CoV-2 offers meaningful protection against its closest bat relatives. Importantly, however, the team also found evidence for limited cross-neutralisation across the entire subgenus, suggesting that even the more distantly related specialist viruses are not completely invisible to immunity primed by SARS-CoV-2 infection. This graded pattern of cross-reactivity maps closely onto the phylogenetic and receptor-usage relationships the researchers had established.

Using monoclonal antibodies derived from COVID-19 vaccinees who subsequently experienced breakthrough infections, the researchers were able to pinpoint which classes of antibody epitopes are responsible for the broader neutralisation observed across the sarbecovirus panel. Because antibodies recognise specific structural features of the RBD, identifying the epitope classes that mediate cross-neutralisation provides a rational basis for designing vaccines and therapeutics with deliberately broad coverage. Antibodies directed against more conserved features of the receptor-binding interface, rather than those specific to SARS-CoV-2’s particular configuration, appear to underpin the wider neutralising activity.

Taken together, the study delivers a unifying message: generalist ACE2 usage, phylogenetic proximity to SARS-CoV-2, and antigenic similarity travel together. A bat sarbecovirus that can flexibly use receptors from many mammalian species is likely to be a close relative of SARS-CoV-2 and likely to be partially neutralised by existing human immunity. This constellation of traits offers surveillance teams a practical framework for triage. When a new sarbecovirus is discovered, characterising its receptor-binding breadth through binding and pseudotype assays could provide an early, laboratory-based assessment of both its zoonotic potential and the degree to which current vaccines and antibodies might protect against it. As bat habitats are disturbed and human-wildlife interfaces expand, such tools for distinguishing the generalists from the specialists among the thousands of circulating bat coronaviruses could prove essential for anticipating, and perhaps preventing, the next spillover.

Subject of Research: ACE2 receptor usage breadth as a predictor of host range and antigenic relatedness across bat sarbecoviruses

Article Title: Breadth of ACE2 receptor usage predicts host range and antigenic relatedness across bat sarbecoviruses

Article References: Thakur, N., Newman, J., Ni, D., Seow, J., Hay, A. L., Lee, Y., Upadhyay, A., Ekundayo, B. E., Hammond, J. A., Peacock, T. P., Lau, K., Doores, K. J., & Bailey, D. (2026). Breadth of ACE2 receptor usage predicts host range and antigenic relatedness across bat sarbecoviruses. PLOS Biology, 24(10), e3003944. https://doi.org/10.1371/journal.pbio.3003944

Image Credits: AI Generated

DOI: 10.1371/journal.pbio.3003944

Keywords: sarbecoviruses, ACE2, SARS-CoV-2, host range, receptor-binding domain, antigenicity, cross-neutralisation, bat coronaviruses, zoonotic spillover, Omicron, monoclonal antibodies, pseudotype assays

Major TV networks were notified on Friday that the department was examining whether they violated antitrust laws when they suspended pool coverage of President Trump.

Our journalists Sheera Frenkel and Dylan Freedman break down what A.I. agents are, how they differ from chatbots and why A.I. companies are worried about them now.

A tech start-up’s stunt in San Francisco tested the boundaries of combat sport safety and regulations.

A new mode includes a study tool, but it still does a user’s homework. And a children’s safety nonprofit says the chatbot flunked its tests.

Heart and blood vessel diseases are common in people living with Alzheimer’s disease and Parkinson’s disease. Many of these patients take medicines for conditions such as high blood pressure, heart failure or an irregular heartbeat, so doctors need to regularly consider whether each medicine remains helpful as the disease progresses. New doctoral research from the […]

The post Heart Drug Use Changes After Alzheimer’s and Parkinson’s appeared first on Knowridge Science Report.

Aujourd'hui, la réutilisation des eaux usées pour refroidir les data centers est en train de devenir un levier de préservation des ressources hydriques et de protection de l'environnement alors que ces infrastructures sont en pleine expansion partout dans le monde. 

Meta a du mal à faire décoller ses IA, alors la firme a pensé autrement avec sa nouvelle application Muse. Plutôt que de proposer un chatbot, le groupe de Mark Zuckerberg mise sur une autre bataille : celle des agents capables d’agir à la place de l’utilisateur. Et les premiers chiffres montrent...

La reducción de peso en los vehículos es una prioridad global para disminuir las emisiones de CO2 y mejorar la eficiencia energética. Un nuevo estudio evalúa el uso de tecnologías de moldeo por inyección microcelular combinadas con fibras largas de vidrio para obtener espumas de polipropileno, componentes plásticos más ligeros que tienen una rigidez superior a los materiales convencionales y reducen el impacto ambiental en un 17 %.

Quantum mechanics may be one of the most precisely tested paradigms in science, but there’s still no universally accepted interpretation of what it tells us about reality. How do we get from the wave-like behavior of quantum systems to the solid, macroscopic world of objects and the universe at large? Jonathan Halliwell, a professor of theoretical physics at Imperial College London…

Source

Le immagini ad alta risoluzione della sonda Lunar Reconnaissance Orbiter della NASA hanno rivelato un recente impatto sulla faccia nascosta della Luna. Un asteroide o frammento cometario ha scavato una cavità di oltre 200 metri di diametro, sollevando detriti incandescenti e dimostrando la continua vulnerabilità del suolo lunare al bombardamento cosmico.

Confermata l'esistenza dell'esopianeta più giovane mai individuato, un pianeta della massa di Giove a 450 anni luce da noi che sta rivoluzionando i modelli sulla formazione dei sistemi planetari.

Gli astronomi hanno catturato in tempo reale gli esiti di una devastante collisione frontale tra due giovani pianeti in orbita attorno alla stella Gaia20ehk. L'impatto ha generato una gigantesca nube di detriti e polveri incandescenti che ha oscurato la luce visibile della stella, provocando al contempo un forte picco di emissione infrarossa. L'evento, avvenuto a una distanza dalla stella pari a quella tra la Terra e il Sole, offre una rara finestra osservativa sui processi violenti che quattro miliardi di anni fa portarono alla formazione della Luna.

Chinese President Xi Jinping suffered a severe stroke in India and, after refusing treatment in the country, may now be suffering with long-lasting effects, it has been claimed by his political opponents.

The post Xi Jinping “Suffers Severe Stroke” in India appeared first on The Daily Sceptic.

Gli astronomi hanno scoperto 84 misteriose sorgenti di raggi X in sei galassie vicine. Chiamate “hypersoft X-ray sources”, potrebbero essere sistemi binari contenenti nane bianche, stelle di neutroni o buchi neri e aiutare a risolvere due importanti enigmi dell'astrofisica.

Nuove analisi digitali di un'antica iscrizione suggeriscono che Meretneith, vissuta circa 5.000 anni fa, potrebbe aver governato l'Egitto come una vera sovrana durante la Prima Dinastia.

Uno studio giapponese durato dieci anni ha rilevato un'associazione tra sanguinamento delle gengive e rischio di demenza e Alzheimer. Il gruppo con più sanguinamento presentava un rischio di Alzheimer del 61% più elevato, ma la ricerca non dimostra che i problemi gengivali siano una causa della malattia.

Los fósiles de Mandrasuchus milleri revelan que los primeros representantes del linaje de los aligátores ya prosperaban en Norteamérica pocos cientos de miles de años después de la gran extinción.